Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Stryker Corp banner

Stryker Corp
LSE:0R2S

Watchlist Manager
Stryker Corp Logo
Stryker Corp
LSE:0R2S
Watchlist
Price: 293.4419 USD -5.53% Market Closed
Market Cap: $112.3B
Write Note Create Alert

Intrinsic Value

0R2S price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

Is 0R2S undervalued or overvalued?

See the intrinsic value estimate for Stryker Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

0R2S Intrinsic Value
LOCKED
Unlock
Today vs. history

0R2S looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 0R2S’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 0R2S
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price $293.44
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 0R2S

Fundamental Analysis

What Stryker Does

Health Care

Stryker makes medical devices and hospital equipment that help doctors treat injuries, replace damaged joints, and perform surgery. Its products include hip and knee implants, surgical tools, operating-room systems, trauma devices, and equipment used in emergency rooms and ambulances. It also sells products for neurovascular care, which are used in treating certain stroke and brain conditions.

Headquarters
United States of America US
Employees
56 000
IPO date
Mar 17, 1980
Read the full company overview
View Company Overview

Stryker has a wide economic moat

No Moat Narrow Wide

Replacing familiar surgical tools and procedures takes retraining and changes to hospital equipment, giving surgeons and hospitals practical reasons to stay with Stryker. Patents covering its implants and Mako robotic technology also prevent competitors from simply copying protected designs.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Stryker Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

SYK Insider Trading
Buy and sell transactions by insiders

Continue 0R2S Research

Summary
0R2S intrinsic value, competitors valuation, and company profile.
DCF Valuation
0R2S stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0R2S stock valuation using valuation multiples.
Wall St Estimates
0R2S price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0R2S stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Stryker Corp listings:
NYSE • USD
SYK
 XETRA • EUR
SYK
 F • EUR
SYK
 XMUN • EUR
SYK
 SWB • EUR
SYK
 DUS • EUR
SYK
Discover More
What is the Intrinsic Value of one 0R2S stock?

The intrinsic value for Stryker Corp (0R2S) under the Base Case is hidden USD.

Is 0R2S stock undervalued or overvalued?

Compared with the current market price of 293.4419 USD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.